Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bioventus (BVS) Exchange Rate Effect (2020 - 2025)

Bioventus' Exchange Rate Effect history spans 6 years, with the latest figure at $133000.0 for Q4 2025.

  • For Q4 2025, Exchange Rate Effect rose 106.45% year-over-year to $133000.0; the TTM value through Dec 2025 reached $371000.0, up 114.49%, while the annual FY2025 figure was $371000.0, 114.49% up from the prior year.
  • Exchange Rate Effect reached $133000.0 in Q4 2025 per BVS's latest filing, up from -$394000.0 in the prior quarter.
  • In the past five years, Exchange Rate Effect ranged from a high of $1.1 million in Q4 2022 to a low of -$2.1 million in Q4 2024.
  • Average Exchange Rate Effect over 5 years is -$63350.0, with a median of -$10500.0 recorded in 2021.
  • Peak YoY movement for Exchange Rate Effect: soared 749.3% in 2023, then plummeted 660.6% in 2024.
  • A 5-year view of Exchange Rate Effect shows it stood at $149000.0 in 2021, then soared by 606.04% to $1.1 million in 2022, then plummeted by 65.02% to $368000.0 in 2023, then tumbled by 660.6% to -$2.1 million in 2024, then surged by 106.45% to $133000.0 in 2025.
  • Per Business Quant, the three most recent readings for BVS's Exchange Rate Effect are $133000.0 (Q4 2025), -$394000.0 (Q3 2025), and $202000.0 (Q2 2025).